Role of natural killer cell subsets in cardiac allograft rejection

  • M. E. McNerney
  • , K. M. Lee
  • , P. Zhou
  • , L. Molinero
  • , M. Mashayekhi
  • , D. Guzior
  • , H. Sattar
  • , S. Kuppireddi
  • , C. R. Wang
  • , V. Kumar
  • , M. L. Alegre*
  • *Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    110 Citations (Scopus)

    Abstract

    To achieve donor-specific immune tolerance to allogeneic organ transplants, it is imperative to understand the cell types involved in acute allograft rejection. In wild-type mice, CD4+ T cells are necessary and sufficient for acute rejection of cardiac allografts. However, when T-cell responses are suboptimal, such as in mice treated with costimulation-targeting agents or in CD28-deficient mice, and perhaps in transplanted patients taking immunosuppressive drugs, the participation of other lymphocytes such as CD8 + T cells and NK1.1+ cells becomes apparent. We found that host NK but not NKT cells were required for cardiac rejection. Ly49G2 + NK cells suppressed rejection, whereas a subset of NK cells lacking inhibitory Ly49 receptors for donor MHC class I molecules was sufficient to promote rejection. Notably, rejection was independent of the activating receptors Ly49D and NKG2D. Finally, our experiments supported a mechanism by which NK cells promote expansion and effector function of alloreactive T cells. Thus, therapies aimed at specific subsets of NK cells may facilitate transplantation tolerance in settings of impaired T-cell function.

    Original languageEnglish
    Pages (from-to)505-513
    Number of pages9
    JournalAmerican Journal of Transplantation
    Volume6
    Issue number3
    DOIs
    Publication statusPublished - 2006 Mar

    Keywords

    • Costimulation
    • Mouse
    • NK cells
    • Tolerance
    • Transplantation

    ASJC Scopus subject areas

    • Immunology and Allergy
    • Transplantation
    • Pharmacology (medical)

    Fingerprint

    Dive into the research topics of 'Role of natural killer cell subsets in cardiac allograft rejection'. Together they form a unique fingerprint.

    Cite this